Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Magnesium Oxide”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1982

Neutralization of acid in the rumen by magnesium oxide and magnesium carbonate.

Two reagent and two feed grade magnesium oxides and reagent grade magnesium carbonate, sodium bicarbonate, and calcium carbonate were evaluated to ascertain their ability to neutralize acid in the rumen. Rumen fluid pH was increased in vitro, compared to the control, by antacid compounds, and their increased ranked: calcium carbonate less than feed grade magnesium oxide A less than light magnesium oxide and feed grade magnesium oxide B less than heavy magnesium oxide less than magnesium carbonate less than sodium bicarbonate. Titrations at constant pH's ranging from 3.0 to 7.5 indicated that these magnesium compounds were reactive at pH's normally in the rumen although reactivity decreased with increasing pH. Intraruminal doses of feed grade magnesium oxide A and calcium carbonate did not change rumen fluid pH for other compounds ranked: feed grade magnesium oxide B less than magnesium carbonate less than heavy magnesium oxide. Feeding of heavy magnesium oxide or magnesium carbonate increased rumen fluid pH as compared to the control diet. Feeding feed grade magnesium oxide B in three quantities to cattle resulted in proportional increased in fecal pH and fluidity of feces. Two feed grade magnesium oxides differed in their ability to neutralize acid in the rumen.

Animals↗
PubMed1984

Response of milking cows fed a high concentrate, low roughage diet plus sodium bicarbonate, magnesium oxide, or magnesium hydroxide.

To determine the ability of mineral supplements to elevate depressed milk fat percent, we placed 42 Holstein cows in early to midlactation in seven blocks and assigned each to one of six treatments: control (25% corn silage and alfalfa haylage, 75% concentrate, mostly corn, dry matter); control plus magnesium oxide ground to pass a .425-mm sieve; control plus prilled magnesium oxide sieved to between 1.70 and .425 mm; control plus sodium bicarbonate; control plus reactive powdered magnesium oxide to pass a 45 microns sieve; and control plus powdered magnesium hydroxide. Sodium bicarbonate was 1% of diet as fed, magnesium oxide .5%, magnesium hydroxide .7% later reduced to .5%. Cows were fed control ration for 3 wk to induce milk fat depression, then were changed to treatment rations for 5 wk. Five cows (unblocked) were continued on each dietary treatment for a digestibility study after the feeding trial. All mineral supplements produced greater milk fat percent and yield of milk fat per day than control and all magnesium treatments produced greater milk fat percent than sodium bicarbonate. Magnesium oxide passing a .425-mm sieve produced the greatest increase of milk fat percent. Milk production was most for sodium bicarbonate treatment. Supplementation with magnesium increased ruminal magnesium concentration by factors of 1.26 to 3.75. Blood serum, urine, and fecal magnesium concentrations and fecal pH were more for cows fed magnesium than those fed sodium bicarbonate treatments. Kidney filtration ratios of element to creatinine increased for magnesium when diets were supplemented with magnesium and increased for phosphorus and sodium when diets were supplemented with sodium bicarbonate.

Animal Feed↗
PubMed1999

Calcium oxide and magnesium oxide inhibit plasma coagulation by Staphylococcus aureus cells at the lower concentration than zinc oxide.

We examined the effect of ceramic powder slurries on the coagulation of plasma by Staphylococcus aureus cells. Plasma coagulation by S. aureus strains or their cultured supernatant was inhibited in the plasma with 0.12% calcium oxide or 0.25% magnesium oxide after incubation for 24 h at 37 degrees C. Inhibition of plasma coagulation by calcium oxide and magnesium oxide was observed at the lower concentration than zinc oxide.

Antacids↗
PubMed1990

Lactational responses to and in vitro ruminal solubility of magnesium oxide or magnesium chelate.

Thirty-six midlactation Holstein cows were used in a randomized incomplete block design to evaluate lactational responses to varying dietary concentrations of Mg supplemented by MgO or Mg chelate. Basal diet was 41:4:55 corn silage:cottonseed hulls:concentrate (.21% total Mg). Magnesium oxide was added to the basal diet to give .32, .37, and .43% total dietary Mg, and Mg chelate was added to provide .23, .25, and .27% Mg, DM basis. Dietary treatments were formulated to supply equal concentrations of bioavailable Mg from either Mg source. Dry matter intake and milk yield were greater by cows fed MgO-supplemented than Mg chelate-supplemented treatments. Milk fat percentages were not affected. Milk protein percentages increased with Mg chelate compared with protein percentages with MgO. Treatments did not affect gross efficiency (4% FCM/DM intake) or body weight change. Lack of response to Mg chelate suggested that either the bioavailability was not as high as assumed or that sufficient total bioavailable Mg was not provided in those treatments. A companion in vitro experiment showed that MgO-supplemented concentrates, with more total supplemental Mg, supplied two to three times more soluble Mg than Mg chelate-supplemented concentrates.

Animal Feed↗
PubMed1989

Effect of reactivity rate and particle size of magnesium oxide on magnesium availability, acid-base balance, mineral metabolism, and milking performance of dairy cows.

Four ruminally fistulated Holstein cows were arranged in a 4 x 4 Latin-square design. Treatments consisted of a control diet and three diets containing 4% MgO (DM basis) with increasing reactivity rates (A, B, C). Diets contained corn silage and concentrate at a 40:60 ratio (DM) and were fed at 95% of ad libitum intake. Total acid-consuming capacity and solubility of MgO in vitro paralleled particle size and agreed with the solubilities in the rumen. Milk fat percentage, but not milk yield, was increased by all three MgO diets. Ruminal pH was elevated by the MgO diets across all 8 h postfeeding. MgO, reactivity A diet tended to increase ruminal acetate, total VFA production, milk yield, milk fat yield, and milk fat percentage. Effect of time postfeeding on acetate and propionate production was significant; 2 to 6 h postfeeding was the period most responsive to the diets. No significant influence on blood acid-base balance was observed. On the basis of urinary excretion of Mg, MgO sources with smaller particles are more available to cattle. Both Ca and Cl metabolism appeared to be affected by reactivity rate of MgO.

Acid-Base Equilibrium↗
PubMed1990

Bioavailability of magnesium in beef cattle fed magnesium oxide or magnesium hydroxide.

Two experiments were conducted to compare Mg bioavailability from Mg oxide (MgO) vs Mg hydroxide (Mg(OH)2) fed in either a completely mixed diet or a mineral supplement. In Exp. 1, these Mg sources were incorporated into completely mixed diets and offered to 15 steers (282 kg) allotted to three treatments: control diet containing .19% Mg, control plus .2% added Mg as MgO, or control plus .2% added Mg as Mg(OH)2. Each calf was fed 5 kg/d of the respective diet during 10-d adjustment and 7-d collection periods. Blood samples were collected on d 1, 3 and 7. Mg supplementation increased (P less than .01) fecal and urinary Mg excretions, whereas apparent Mg absorption (%) and retention were similar (P greater than .10) for all treatments. Plasma Mg concentrations were similar (P less than .10) for calves supplemented with MgO and Mg(OH)2 but were higher (P less than .05) for Mg supplemented than for control calves on d 7. In Exp. 2, these Mg sources were incorporated into mineral supplements and offered free choice to 30 spring-calving beef cows gazing tetany-inducing pastures from March 6 to May 1. Each of three groups of 10 cows was assigned to a 5.7-ha tall fescue pasture and offered either a control supplement or a supplement containing 40% MgO or Mg(OH)2. Blood samplers were collected on d 0, 7, 14, 28, 42 and 56. Plasma Mg concentrations were not different (P greater than .10) for cows offered MgO and Mg(OH)2 but were higher (P less than .01) for Mg-supplemented than for control cows on d 28, 42 and 56.(ABSTRACT TRUNCATED AT 250 WORDS)

Absorption↗
PubMed1990

Magnesium bioavailability from magnesium citrate and magnesium oxide.

This study compared magnesium oxide and magnesium citrate with respect to in vitro solubility and in vivo gastrointestinal absorbability. The solubility of 25 mmol magnesium citrate and magnesium oxide was examined in vitro in solutions containing varying amounts of hydrochloric acid (0-24.2 mEq) in 300 ml distilled water intended to mimic achlorhydric to peak acid secretory states. Magnesium oxide was virtually insoluble in water and only 43% soluble in simulated peak acid secretion (24.2 mEq hydrochloric acid/300 ml). Magnesium citrate had high solubility even in water (55%) and was substantially more soluble than magnesium oxide in all states of acid secretion. Reprecipitation of magnesium citrate and magnesium oxide did not occur when the filtrates from the solubility studies were titrated to pH 6 and 7 to stimulate pancreatic bicarbonate secretion. Approximately 65% of magnesium citrate was complexed as soluble magnesium citrate, whereas magnesium complexation was not present in the magnesium oxide system. Magnesium absorption from the two magnesium salts was measured in vivo in normal volunteers by assessing the rise in urinary magnesium following oral magnesium load. The increment in urinary magnesium following magnesium citrate load (25 mmol) was significantly higher than that obtained from magnesium oxide load (during 4 hours post-load, 0.22 vs 0.006 mg/mg creatinine, p less than 0.05; during second 2 hours post-load, 0.035 vs 0.008 mg/mg creatinine, p less than 0.05). Thus, magnesium citrate was more soluble and bioavailable than magnesium oxide.

Adult↗
PubMed2001

Unexpected Fe local order in iron oxide coated nanocrystalline magnesium oxides with exceptional reactivities against environmental toxins.

Mg oxide nanoparticles are very reactive materials used to mitigate atmospheric pollution and to sequester polluting molecules. Using Fe K-edge XAFS, we have studied the structure of iron oxide-coated MgO nanoparticles before and after reaction with CCl4. Before reaction, the local structure around Fe is totally different from that in iron oxide coatings on SrO and CaO nanoparticles, although these coated materials were prepared in the same way. In SrO and CaO, the iron oxide coating has been shown to be well separated from the bulk of the nanoparticle, whereas in MgO, Fe was found to mix with MgO. After reaction with CCl4, Fe-Cl bonds can be detected when the coated nanoparticle is saturated. Such Fe-Cl EXAFS signals have not been observed in previously studied nanoparticles.

Air Pollutants↗
PubMed1983

Effect of supplemented magnesium from magnesium oxide or dolomitic limestone upon digestion and absorption of minerals in sheep.

Three metabolism trials were conducted with six lambs fitted with abomasal and ileal cannulae to determine the site of supplemental Mg absorption when supplied as dolomitic limestone or magnesium oxide. Magnesium intake was 1.09 g/d for the lambs fed the control diet and 2.21 and 2.10 g for those fed the dolomitic limestone and magnesium oxide supplemented diets, respectively. Irrespective of its source, the major site of Mg absorption was the preintestinal region. Magnesium was secreted in the small intestine in lambs fed all three diets. Magnesium supplementation resulted in an increase (P less than .05) in preintestinal Mg absorption, with magnesium oxide having the highest value. Supplementation had no effect (P greater than .05) on secretion or absorption of Mg from the small and large intestines or total retention of Mg. With all three diets, the major site of Ca absorption was the stomach region with additional absorption taking place in the large intestine. Calcium was secreted in the small intestine of lambs fed all treatments. Generally, K, Na and P were secreted in the preintestinal region and absorbed from the small and large intestines. The major site of K and P absorption appeared to be the small intestine and for Na, the large intestine. Serum minerals were unchanged (P greater than .05) due to treatment, but the levels of Mg, K and inorganic P tended to be higher in lambs supplemented with either of the Mg sources. It appears that the greater utilization of Mg from magnesium oxide vs dolomitic limestone is due to greater absorption of Mg from the forestomach region.

Animals↗
PubMed1991

[Photometric method of the detection of magnesium oxide in the working zone air after using magnesium caustic dust].

The contributors proposed a new highly sensitive selective technique of magnesium oxide detection, based on the Congo red and salicylic acid reaction. The minimal detection level is 0.25 mg of magnesium oxide in the analyzed sample volume. The range of measured concentrations varies from 0.01 to 0.4 mcg/ml. The express technique is simple and selective with Ca (II), Fe (III), AI (III).

Air Pollutants, Occupational↗
PubMed1990

Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.

The effect of magnesium citrate and magnesium oxide on urinary biochemistry and on the crystallization of calcium salts was examined in 7 normal subjects and 4 patients with recurrent calcium oxalate nephrolithiasis. When magnesium citrate or magnesium oxide was administered on an empty stomach (10 mEq. 4 times per day or 486 mg. magnesium per day for 2 weeks) urinary magnesium increased by only 77 to 79 mg. per day and urinary citrate increased by 98 to 142 mg. per day. However, urinary calcium increased by 21 to 25 mg. per day. No significant changes were noted in urinary saturation of calcium oxalate or brushite or in the limit of metastability (formation product) of these salts. However, when magnesium salts were provided with meals there were more prominent increases in urinary magnesium (by 92 to 96 mg. per day) and in citrate (by 218 to 226 mg. per day). Moreover, urinary oxalate decreased. Owing to these changes the urinary saturation of calcium oxalate decreased and the formation product increased. If magnesium citrate and magnesium oxide are to be used in the management of recurrent calcium oxalate nephrolithiasis, they should be administered with meals.

Adult↗
PubMed1990

A prospective randomized comparison of oral terbutaline and magnesium oxide for the maintenance of tocolysis.

We compared oral magnesium oxide with oral terbutaline sulfate in a prospective, randomized manner to determine efficacy and side effects. Preterm labor patients whose labor was arrested with parenteral tocolysis were randomized to oral tocolysis with either magnesium oxide, 200 mg every 3 to 4 hours (n = 23), or terbutaline, 2.5 to 5 mg every 3 to 4 hours (n = 27). The number of patients who were delivered of infants before 36 weeks' gestation was similar between groups (18.5% receiving terbutaline versus 17.4% receiving magnesium). At least one side effect occurred in 81.5% of patients in the terbutaline group and 47.8% in the magnesium group (p less than 0.01). Finally, the cost for 1 day of magnesium (20 cents) is approximately one third the cost of terbutaline (56 cents). These data suggest that oral magnesium oxide is as effective as terbutaline for the maintenance of tocolysis, with fewer side effects and at a lower cost.

Administration, Oral↗
PubMed1985

Dietary magnesium oxide interactions with sodium bicarbonate on cows in early lactation.

Thirty-six Holstein cows were fed a diet of 50% concentrate and 50% corn silage (dry matter) for 12 wk postpartum. Treatments were 0, .4, and .8% magnesium oxide with or without .8% sodium bicarbonate in a 2 X 3 factorial arrangement. Dry matter intake was not different among treatments although the combined buffers had higher intake. Milk production was higher for the .4% magnesium oxide treatments either alone or with sodium bicarbonate as compared with either the 0 or .8% magnesium oxide treatments. Ruminal pH was increased with addition of sodium bicarbonate either alone or together with magnesium oxide. Dietary addition of .4% magnesium oxide either alone or with sodium bicarbonate increased total volatile fatty acid in ruminal fluid. Propionate and valerate were depressed in both of the combined buffered diets. Fecal pH was increased with magnesium oxide addition either alone or with sodium bicarbonate. Increasing magnesium oxide increased magnesium in plasma. No interactions in animal performance were significant for the two buffers.

Ammonia↗
PubMed1971

Chromatography of unusual lipids on thin layers of magnesium oxide.

The chromatographic behavior of some minor components of natural lipids was studied using layers of magnesium oxide and of commercial adsorbents containing magnesium oxide. The lipids investigated included wax esters, cholesteryl esters, diester waxes, and esters, ethers and ether-esters of ethanediol and glycerol. Pronounced differences were found in the patterns of separation of certain lipids on magnesium oxide as compared to silica gel and Florisil. The procedures described afford means for the detection of unusual lipids in natural materials, and their isolation.

Cholesterol↗
PubMed1983

Interaction of antacids with antiarrhythmics. V. Effect of aluminium hydroxide and magnesium oxide on the bioavailability of quinidine, procainamide and propranolol in dogs.

The influence of aluminium hydroxide and magnesium oxide on the oral bioavailability of quinidine, procainamide and propranolol in the dog was investigated. The administration of aluminium hydroxide with a quinidine sulfate capsule causes a significant decrease of maximal plasma concentration (Cpmax) and a shift in tmax (time to reach Cpmax). The area under the curve is not significantly decreased. Administration of magnesium oxide together with a quinidine sulfate capsule or a sustained-release preparation of quinidine bisulfate causes a significant decrease of both Cpmax and the area under the curve. A shift of tmax was observed for the conventional preparation only. The administration of aluminium hydroxide with procainamide hydrochloride diminishes only Cpmax in a significant way. Administration of magnesium oxide together with procainamide hydrochloride has no influence on the different parameters. Administration of aluminium hydroxide or magnesium oxide with propranolol hydrochloride has a significant negative influence on both the Cpmax and the area under the curve.

Aluminum Hydroxide↗
PubMed1982

Dietary sodium bicarbonate and magnesium oxide for early postpartum lactating dairy cows: effects on production, acid-base metabolism, and digestion.

In two experiments with cows in early lactation fed 40% corn silage and 60% concentrate diets (dry basis), we examined effects of 1.0% dietary sodium bicarbonate and .8% magnesium oxide in a 2 x 2 factorial arrangement on performance, acid-base metabolism, and digestion. In Experiment 1 with 20 Holstein and 4 Jersey cows, intake and milk production were not affected by treatment through 12 wk postpartum. In digestion trials at 3, 6, 9, and 12 wk postpartum, addition of magnesium oxide increased digestibility of dry matter 1.8% units by sodium bicarbonate whereas acid detergent fiber digestion increased 9 to 12% units with addition of either buffer. In Experiment 2, with four fistulated Holstein cows in a Latin square design, intake per unit body weight was increased .18% units by dietary sodium bicarbonate while milk production was unaffected. Dry matter and acid detergent fiber digestion were increased slightly by sodium bicarbonate plus magnesium oxide addition whereas nitrogen balance increased 23 g/day in cows fed magnesium oxide alone. Because of the low fiber content of the ration, milk fat percent increased .5 to .9% by addition of either buffer in both experiments and resulted in corresponding increased in fat-corrected milk. Sodium bicarbonate and magnesium oxide prevented rapid declines in rumen pH associated with feeding in Experiment 2, which related to changes in acid detergent fiber digestion. Blood acid-base metabolites were relatively unchanged by treatment in either experiment. Urinary bicarbonate and net acid excretion rates were changed on the average by +41 and +43 meq/h by sodium bicarbonate or magnesium oxide but could not be related to changes in intake and production.

Acid-Base Equilibrium↗
PubMedDate not supplied

[Magnesium oxide and tocolysis. Our clinical experience and comparison with beta-mimetic (isoxusprine) therapy].

The authors propose the use of oral Magnesium Oxide in the quantity of 200 mg every 3-4 hours for the tocolytic treatment of the pre-term pain, once intravenous tocolysis has decreased or stopped uterine activity (since it has considerably more rapid effect). This treatment constitutes a valid alternative to the use of Beta Mimetic agents in all cases where their use is contraindicated. In the present study, we followed one heterogeneous group of 130 patients, suffering from premature labor hospitalized in our department. After decreasing the uterine contractions by intravenous isossuprine, sixty patients were subsequently treated with magnesium Oxide, fifty with oral isossisuprine, twenty with a simple antispasmodic and the remaining constituted the control group. The percentage of pre-term births has been almost the same in the first two groups (around 17%). The percentage of the patients who exhibited side effects of Beta Mimetic was 30-40%, against 2% of the patients treated with Magnesium Oxide. The intensity of the symptoms was however so slight in the patients treated with Magnesium Oxide, that it failed to disturb the compliance of the patients which allowed to continue the therapy for the necessary period.

Adrenergic beta-Agonists↗